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ABSTRACT
Ames dwarf mice (df/df) display delayed aging relative to their normal siblings, living
approximately 40-60% longer. As such, investigating the mechanisms that enable these
organisms to have superior life expectancies may prove useful in developing therapies to
slow aging and deter age-related disease. Nonalcoholic fatty liver disease (NAFLD) is a
condition that is characterized by the accumulation of excess adipose tissue in the liver.
Interestingly, its prevalence tends to increase with age with an incidence rate of greater
than 40% in individuals over the age of 60. Previous studies highlight the potential of
calorie restriction (CR) in promoting longevity, but little is known about its effects on the
biomolecular processes that govern NAFLD. In this study, we explored the livers of Ames
dwarf mice following 6 months of continuous calorie-restriction and discovered significant
down regulation of candidate miR-34a, an established biomarker for fatty liver. Using
qPCR and western blot, we found miR-34a to be correlated with the expression of agerelated and lipid trafficking mRNA and protein. Specifically, CR upregulated Sirt1 in the
Ames dwarf liver and subsequently induced gluconeogenesis and lipid catabolism. To
verify the role of miR-34a in influencing fatty acid metabolism, we transfected the human
liver cancer (HepG2) cell line with miR-34a mimic and observed its effect on direct targets
SIRT1, AMPKa, and PPARa which are believed to influence downstream lipid transport
genes. In all, our findings suggest that CR is a robust driver of the SIRT1 signaling
pathway which reverses the pathology associated with age-related diseases by
influencing insulin signaling in the Ames dwarf liver thereby improving fatty acid oxidation
and cholesterol efflux and maintaining lipid turnover via autophagy.
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INTRODUCTION
Nonalcoholic fatty liver disease (NAFLD) is an idiopathic metabolic disorder that
affects roughly 83 million Americans, with an incidence rate of 40% in the elderly
population. Although the pathogenesis of this condition is poorly understood, it is believed
to be influenced by unhealthy lifestyle choices such as excess energy intake.[1, 2]
Presently, dietary intervention and physical activity are the only options that exist to
stagnate the progression of this age-related illness, but compliance to these regimens is
often failed with strict adherence by only 50% of patients.[3] Due to the indefinite
commitment to these non-medicinal treatments, it is imperative to discover breakthrough
therapies that may potentially mitigate NAFLD, enhance the healthspan, and improve the
quality of life.
Calorie restriction (CR) is regarded as an intervention capable of significantly
lengthening the lifespan. Alongside, CR has other benefits including decreased body
weight, reduced cholesterol levels, and improved insulin sensitivity.[4, 5] Notably, the
effects of CR on aging are believed to be the product of changes in gene expression that
may be influenced by metabolic processes including lipid trafficking.[6] Previous studies
elucidate the protective effects of calorie restriction (CR) induced autophagy against
cellular senescence, but little is known about its role in the biomolecular processes that
regulate NAFLD.[7] Understanding the metabolic profile of the liver in response to CR
may enable the discovery of novel targets and subsequently lead to the production of
more viable remedies to treat NAFLD.
MicroRNAs (miRNAs) are a group of ubiquitous, small noncoding RNAs about 25
nucleotides in length that regulate the process of post-transcriptional gene expression.
1

These endogenous molecules bind to the 3’ untranslated region of messenger RNA’s
(mRNAs) to block translation and prompt degradation of mRNA. [8] As such,
understanding the role of miRNAs in aging may prompt the discovery of treatments to
combat age-associated diseases. Recently, miR-34a has emerged as a proposed
biomarker of liver disease with assumed influence on SIRT1 and adenosine
monophosphate-activated protein kinase (AMPK), coregulators of energy metabolism.
Particularly, the NAD-dependent deacetylase silent information T1 (SIRT1) gene is a
facilitator of healthy aging and is known to inhibit oxidative stress and support DNA
stability.[9] AMPK is activated by high AMP to ATP ratio due to low cellular energy,
inducing catabolism.[9] Alongside, miR-34a has been reported to target peroxisome
proliferator-activated receptor-a (PPARα), a transcription factor that maintains the activity
of fatty acid metabolizing genes.[10] As such, we suppose that CR may improve lipid
turnover by suppressing the expression of miR-34a making it a viable therapy to examine
in understanding NAFLD.
Ames dwarf mice (df/df) are natural mutants of the prophet of pituitary factor-1
(Prop1) gene, resulting in pituitary hypoplasia.[11] Consequently, they exhibit deficiencies
in growth hormone (GH), prolactin (PRL), and thyroid stimulating hormone (TSH). [12] As
a byproduct of these distinct hormonal inadequacies relative to wild-type mice, df/df mice
display delayed aging, living 40-60% longer than normal mice.[11] Alongside, Ames dwarf
mutants are characterized with enhanced insulin signaling and reduced body fat, which
minimizes the risk of developing metabolic diseases.[5] This makes the df/df genotype a
valuable animal model by enabling the possibility of uncovering biomolecular processes
that may extend human life.

2

We hypothesize that CR mediates changes to dysregulated metabolic pathways
and curbs the pathology of age-related diseases by improving carbohydrate metabolism
through increased glucose disposal thereby prompting fatty acid oxidation and
maintenance of lipid homeostasis. In all, we seek to understand the mechanism by which
CR and the df/df genotype modulate age-related diseases in liver tissue and secondly the
role that miRNAs have in this process. Specifically, we believe that downregulation of
miR-34a in the liver tissue due to calorie restricted diet may contribute to improved lipid
metabolism and decrease the susceptibility to NAFLD. To verify that the overexpression
of miR-34a impairs these processes, we transfected human hepatocellular carcinoma
cells and investigated the effects on upstream and downstream metabolic genes.
Altogether, this data elucidates the mechanism by which CR and df/df genotype help
maintain lipid homeostasis in the liver thereby allowing us to find novel targets and ways
to create unprecedented treatments to combat NAFLD and restore liver function in the
elderly population.
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LITERATURE REVIEW
2.1: The Liver and its role in metabolic homeostasis
The human body relies on dietary lipids, carbohydrates, and proteins as a source
of fuel for cellular functions. Specifically, these macromolecules are broken down into
their chemical building blocks by the digestive system and subsequently absorbed into
the blood stream. This nutrient-rich blood, containing fatty acids, glucose, and amino
acids, is transported to the liver via the hepatic portal vein and expended during cellular
respiration. As such, the liver is a vital metabolic instrument that plays a central role in
controlling energy balance.[13]
Cellular respiration is a series of oxidation-reduction reactions that permits cell
survival.[5] It involves three central metabolic stages: glycolysis, the citric acid cycle, and
oxidative phosphorylation. During glycolysis, fuel sources are converted into two
molecules of pyruvate, adenosine triphosphate (ATP), the principal energy currency of
the cells, and nicotinamide adenine dinucleotide (NADH). Thereafter, pyruvate enters the
mitochondrial matrix and is transformed into acetyl coenzyme A (acetyl CoA). Acetyl coA
is oxidized by the citric acid cycle to generate the production of ATP and the electron
carriers NADH and flavin adenine dinucleotide (FADH2). Lastly, electrons obtained from
NADH and FADH2 combine with oxygen to yield ATP. ATP depletion causes cell death
and is correlated with increased generation of mitochondrial reactive oxygen species
(ROS) resulting in accelerated aging and susceptibility to age-related diseases.
Notably, the production of NADH and subsequent assembly of ATP is driven by
the fuel-sensing enzymes SIRT1 and AMPK.[9] Low cellular energy elevates the
NAD+/NADH and AMP/ATP ratios, which stimulates NADH and ATP production and
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prompts cellular activity.[9] The accumulation of excess adipose deposits due to
hypercaloric diet impairs these metabolic signaling pathways and predisposes individuals
to imminent liver injury.[7] To elaborate, the etiology of NAFLD is attributed to long-term
overnutrition which subsequently induces de novo lipogenesis, mitochondrial dysfunction,
compromised very low-density lipoprotein (VLDL) assembly and maturation, and
diminished cholesterol efflux provoking inflammation, oxidative stress, and damage in the
endoplasmic reticulum (ER). [13, 14]

2.2 De novo lipogenesis
Particularly, nutritional surplus elevates glucose and insulin levels thereby inducing
lipogenesis through activation of sterol regulatory binding-element 1c (SREBP1c), and
downstream genes acetyl CoA carboxylase (ACC) and stearoyl CoA desaturase 1
(SCD1). In addition, high fat diet activates peroxisome proliferator-activated receptor
gamma (PPAR-γ) and results in the hepatic acquisition of chylomicron remnants and free
fatty acids through the translocase CD36. These triglyceride-rich particles are typically
metabolized in the mitochondria via beta-oxidation or fused with apolipoprotein B100
(APOB100) and secreted into the bloodstream. [15]

2.3: Mitochondrial Fatty Acid Oxidation and Lipid Trafficking
Fatty acid oxidation is prompted by peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC-1α) and peroxisome proliferator-activated receptor
alpha (PPARα) signaling.[16] In turn, this increases the expression of carnitine
palmitoyltransferase-1 (CPT1) which catalyzes the transport of fatty acids to the
mitochondrial membrane for ensuing oxidation. Meanwhile, hepatic ER to Golgi lipid
transport is facilitated by apolipoproteins and plays an important role in controlling
5

intracellular trafficking.[17] Namely, with the assistance of microsomal triglyceride transfer
protein (MTTP), apoB100 undergoes lipid extension in the endoplasmic reticulum and is
developed into VLDL particles. Due to their large size, VLDL requires transport vesicles
(VTV) and fusion proteins to move to the Golgi apparatus. VTVs bud off of the plasma
membrane of the ER using the COPII secretion associated ras related GTPase 1a and
1b (SAR1a and SAR1b) coat proteins.[17] Thereafter, VLDL cargo is docked to the Golgi
apparatus by Sec22b-Syntaxin5a (STX5a) complexes, released from the liver, and
converted into potentially pro-atherogenic low density lipoproteins (LDL).[17] Given the
deleterious effects of LDL, the liver must efficiently remove VLDL and process cholesterol.

2.4 Reverse Cholesterol Efflux
In order to maintain healthy cholesterol balance, the liver relies on reverse
cholesterol transport and bile acid biosynthesis. Cholesterol from peripheral tissues is
packaged into high density lipoproteins (HDL) and shipped to the liver by apolipoproteins
A1, AIV, and E (APOA1, APOA4, and APOE).[14, 18, 19] When intracellular hepatic
cholesterol levels increase, bile acids are synthesized through the activation of
cholesterol 7α-hydroxylase (CYP7A1). Alongside, the liver orphan receptor (LXR) inhibits
further cholesterol deposition and stimulates cholesterol efflux through upregulation of
ATP-binding cassette sub-family G member 5 (ABCG5). [20]

2.5 Implications of Calorie Restriction on NAFLD
NAFLD is a multifactorial disease that can be regulated by dietary interventions
that target these different mechanisms.[14] The dynamic nature of the internal human
environment compels organisms to adapt to unforeseeable and volatile feeding conditions
by utilizing metabolic switching. Due to fluctuations in nutrient availability during the
6

anabolic and catabolic states, different oxidation pathways are made readily available to
fuel the energy demands of cells. To elaborate, the consumption of food triggers
postprandial glucose abundance thereby eliciting insulin secretion. Insulin accelerates the
absorption of blood glucose by the plasma membrane glucose transporters (GLUT2) of
the hepatocytes and encourages the synthesis of glycogen and fatty acids.[21] Leftover
glucose is shuttled to the peripheral tissues to enable various cellular functions.
Meanwhile,

during

the

post-absorptive

state

glucagon

induces

lipolysis

and

gluconeogenesis due to limited glucose reservoirs. Fatty acid oxidation is the preferred
route of energy production and allows the cells to carry out their life-sustaining
functions.[5, 13] Therefore, CR is a potential cure-all that could counteract the detrimental
effects of nutritional overload by mimicking fasting, inducing the hydrolysis of triglycerides
and influencing the expression of these powerful lipid trafficking genes and proteins.
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Figure 1: Biomolecular Aspects of Fatty Liver. Fuel molecules are transported to
the hepatic portal vein where they are metabolized to generate ATP. During
nutritional surplus, SIRT1 and AMPK sensors are downregulated due to excess
energy reserves. The pathogenesis of NAFLD involves increased de novo
lipogenesis, which is induced by the activation of SREBP. In turn, steatos is triggers
impaired mitochondrial function, VLDL transport, and cholesterol efflux resulting in
oxidative stress. (Created with BioRender.com.)
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METHODS
3.1: Transfection of Cell lines
Human HEPG2 cell lines were generously donated from the laboratory of Dr.
Shadab Siddiqi and cultured in 50:50 Dulbecco’s Modified Eagle Medium/Ham’s Nutrient
Mixture F-12 (DMEM/F12; Corning, Manassas, VA, USA) supplemented with Lglutamine, 10% fetal bovine serum (FBS; Corning, Woodland, CA, USA) and 1%
antibiotics (5000units/mL penicillin and 5000ug/mL streptomycin; Gibco, Grand Island,
NY, USA) at 37°C with 5% CO2.
At 80% confluency, HEPG2 cells were washed in phosphate buffered saline
(Corning, Manassas, VA, USA) and dissociated from the culture dish using 0.25% trypsinEDTA (Gibco, Grand Island, NY, USA). After trypsin inactivation, cells were pelleted via
centrifugation at 125g for 7 minutes and resuspended in antibiotic-free, FBS
supplemented 50:50 DMEM/F12 media.
Using an automated cell counter (Corning CytoSmart), cells were counted and
seeded at a density of 2.0*10^5 cells/mL with a final volume of 2.3mL per well. After two
days, cells were separated into two groups (control, mimic; n=8 per group) and incubated
in 100ul of transfection complexes consisting of 6ul HiPerfect transfection reagent
(Qiagen) in 100ul serum-free DMEM/F12 media, with the mimic group incubated in 5nM
mimic of hsa-miR-34a (Dharmacon). After three hours, 2.2mL of antibiotic-free, FBS
supplemented 50:50 DMEM/F12 was added to the cells. At 48 hours, cells were collected
in 500ul of Trizol (Life Technologies, Carlsbad, CA, USA) and stored in the −80°C for
future analysis.
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3.2: Experimental Design and Animals
Animal protocol was approved by the University of Central Florida Institutional
Animal Care and Use Committee (IACUC). Normal wild-type (N) and Ames dwarf (df/df)
littermates were housed under a 12- hour light and dark cycle at approximately 20-24°C
with unlimited access to food (Rodent Laboratory Chow 5001; not autoclaved; 23.4%
protein, 4.5% fat, 5.8% crude fiber; LabDiet PMI Feeds, Inc., St. Louis, MO). At 3 months
of age, male mice were separated into the following experimental groups (n=8-11 per
group): normal mice fed ad libitum (N-AL), normal mice subjected to 30% calorie
restriction (N-CR), Ames dwarf mice fed ad libitum (df/df-AL), and Ames dwarf mice
subjected to 30% calorie restriction (df/df-CR).
Animals selected for CR were introduced to the regimen with a gradual reduction
of food intake during the first three weeks of the study. Specifically, 90% food intake
during the first week, 80% intake during the second week, and 70% intake thereafter.
Food consumption was measured weekly in efforts to appropriately moderate 30% calorie
restriction relative to the ad libitum controls. At the age of 9 months (6 months of
continuous CR), mice were fasted overnight and sacrificed via cervical dislocation under
sedation with isoflurane. Liver tissue was harvested and snap frozen in liquid nitrogen
with subsequent storage in −80°C for future analysis.

3.3: RNA Extraction and cDNA Synthesis
RNA extraction of liver tissue samples was completed via manufacturer’s protocol
for RNeasy® Mini Kit (Qiagen, Valencia, CA, USA). Briefly, tissues were homogenized in
the Bullet Blender Homogenizer BBX24 (Next Advance, Averill Park, NY, USA) using 500
μl QIAzol® Lysis Reagent and 0.5mm Zirconium oxide beads. Thereafter, samples were
centrifuged at 12,000 rcf for 15 minutes at 4°C and the upper aqueous phase was
10

collected. RNA was purified and eluted using RNeasy® mini spin column and 30 μl of
RNase-free water. Concentrations were measured with spectrophotometer and quality
was ensured to have A260/A280 ≥ 1.9. RNA was stored in −80°C until analysis.
RNA extraction of hepatocytes was completed via the Trizol method. Briefly, cell
lysates were centrifuged in 100ul chloroform for 15 minutes at 12,000rcf in 4°C. The upper
aqueous phase was transferred to a new tube and total RNA was precipitated using 250ul
of isopropanol. Samples were incubated for 10 minutes at −20°C and subsequently
centrifuged for 10 minutes at 12,000rcf in 4°C. Supernatant was discarded and RNA pellet
was washed in 500ul of 75% ethanol. Samples were vortexed briefly and centrifuged for
5 minutes at 7,500rcf in 4°C. Supernatant was removed and RNA was redissolved by airdrying the samples for 10 minutes and then resuspending the pellet in 20ul of nucleasefree water. Thereafter, samples were incubated in a 60°C water bath for 15 minutes.
Concentrations were measured with spectrophotometer and quality was ensured to have
A260/A280 ≥ 1.9. RNA was stored in −80°C until analysis.
Complementary DNA (cDNA) for mRNA was generated with 1ug of total RNA per
reaction using iScriptTM cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA) in
accordance with the manufacturer’s protocol. Samples were diluted 1:5 for qPCR. cDNA
was stored in −20°C.
Complementary DNA (cDNA) for miRNA was generated with 10ng of total RNA
per reaction using TaqMan Advanced miRNA cDNA Synthesis Kit (Applied Biosystems,
Carlsbad, CA, USA) in accordance with the manufacturer’s protocol. Samples were
diluted 1:10 for qPCR. cDNA was stored in −20°C.
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3.4: Quantitative Real-Time Polymerase Chain Reaction (qPCR)
Real-time/Quantitative PCR (qPCR) was conducted on the Quant Studio 7 Flex
System (Applied Biosystems, Foster City, CA, USA) for 40 cycles with an initial denaturing
step at 95°C for 20s, followed by 40 cycles of 1) denaturing step at 95 °C for 1s and 2)
annealing/extension step at 60°C for 20s per cycle, with ramp up of 2.63°C/s and ramp
down of 2.42°C/s. A melt curve was obtained after the qPCR reaction was complete, with
an initial step of 60°C for 60s following a 0.05°C/s ramp up with fluorescence reading over
700s until reaching 95°C and held at this temperature for 15s.
To determine mRNA levels, PCR reaction with SYBR-Green fluorescent dye was
performed in duplicate with 2μL of 1:5 dilution of mRNA cDNA template in 5μL SYBR
Green Master Mix, 0.4μL of 10μM forward and reverse primers (Tables 1 and 2), and
12.6μL nuclease- free water, for a final volume of 20μL. Transcript levels were normalized
to the housekeeping gene β-2-microglobulin (B2M) and calculated as discussed in the
statistics section.
To quantify miRNA levels, real-time PCR was conducted with TaqMan Fast
Advanced Master Mix (Applied Biosystems) and was performed in duplicate with 2.5μL
of 1:10 dilution of miRNA cDNA template in 5μL of 2x TaqMan Fast Advanced Master
Mix, 0.5μL of 20x miRNA primer (TaqMan Applied Biosystems), and 2μL of nuclease-free
water, for a final volume of 10μL. The expression level of experimental miRNA was
normalized to reference miR-16 and calculated with delta-delta Ct (2-ΔΔCt) method
explained in the statistics section.

3.5: Western Blot
Protein was extracted from liver tissues using RIPA lysis buffer with proteasephosphatase inhibitor cocktail. Samples were centrifuged for 10 minutes at 13,200rcf in
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4°C. Thereafter, supernatant consisting of protein homogenate was collected and protein
concentrations were determined by colorimetric method using BCA assay (Pierce,
Rockford, IL, USA).
For low molecular weight targets (syntaxin5a, sec22b, MTTP), 50ug of protein was
loaded onto two 1.5mm, 10% gels. Samples were prepared in Laemmli buffer and
denatured in beta-mercaptoethanol at 99°C for five minutes on a heating block. Gel
electrophoresis was completed at 120V for 100 minutes. Thereafter, polyvinylidene
fluoride (PVDF) membrane was activated in methanol and gels were transferred using
the semi-dry transfer method (Bio-Rad Trans-Blot Turbo Transfer System) for 30 minutes
at 2.5A.
For high molecular weight target (APOB100), 25ug of protein was loaded onto two
1.5mm, 7.5% gels. Samples were prepared in Laemmli buffer and denatured in betamercaptoethanol at 99°C for fifteen minutes on a heating block. Gel electrophoresis was
completed at 120V for 100 minutes. Thereafter, polyvinylidene fluoride (PVDF)
membrane was activated in methanol and gels were transferred overnight at 20V for 16
hours in 4°C.
Using Ponceau stain, protein bands were visualized to ensure successful transfer.
Membranes were washed in 1X TBS-Tween (TBST) to remove the stain and blocked for
one hour with 5% milk in TBST at room temperature. After a brief wash in TBST, the blots
were incubated overnight in 1:200 primary antibody in 3% albumin-TBST at 4°C. The
following day, membranes were washed in TBST three times for 10 minutes each for a
total of 30 minutes. The membranes were incubated in anti-mouse secondary at a
concentration of 1:25,000 in 5% milk-TBST for 45 minutes at room temperature.
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Thereafter, the membranes were washed with TBST three times again for ten minutes
each and imaged in the Licor western blot imager.

3.6: Statistical Analysis
To analyze the relative expression of each gene we used the delta-delta Ct (2-ΔΔCt)
method equation:
−ΔΔCt

2

𝐶𝑡(experimental gene first control sample) −𝐶𝑡(𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑔𝑒𝑛𝑒)
𝐶𝑡(reference gene first control sample) −𝐶𝑡(𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒 𝑔𝑒𝑛𝑒)

= 2

(1)

where Ct(experimental gene first sample) is the cycle of threshold (Ct) of the gene of interest of the
first control sample (constant for each 96-well plate); Ct(experimental gene) is the Ct of the gene
of interest of the analyzed sample; Ct(reference

gene first control sample)

is the Ct of the

housekeeping gene in the first control sample (constant for each 96-well plate); Ct(reference
gene)

is the Ct of the housekeeping gene of the analyzed sample. Thereafter, the values

of the N-AL group were averaged and this number was used in the equation 2-∆∆Ct /
average (2-∆∆Ct control sample ) to calculate fold changes. Lastly, fold change outputs were
averaged to calculate relative expression and this data was used to determine the effect
of treatment and genotype on gene expression.[22]
Statistical analysis for tissue samples was performed by using two-way analysis of
variance (2-way ANOVA) and Tukey’s post-hoc multiple comparison of means. For PCR
data from cells, t-test with Welch’s correction was performed. Outliers were detected via
the Tukey interquartile rule, where values less than 1.5 times the first quartile or more
than 1.5 times the third quartile are considered aberrations in the dataset. Significance
was defined as p<0.05 and all results represented mean ± standard error of the mean
(SEM). Statistics were performed using Sigma Plot v14.0 (Systat Software, Palo Alto, CA,
USA).
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A heatmap was produced to visualize the overall profile of gene expression by
treatment and animal type. To investigate the interaction among the genes, we performed
Spearman’s correlation analysis and showed the pairwise correlation coefficients in
heatmaps. To further evaluate the contribution of each gene to the overall difference
among the different treatments and animal types, we performed principal component
analysis (PCA) and visualized the results on PCA biplots. Statistical analyses for
heatmap, Spearman’s correlation, and PCA biplots were performed using Stata MP 15
(StataCorp LLC, 2019) and R packages. All tests were two-tailed with a significant level
of α (type I error) <0.05.
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Table 1: Mus musculus Primers

Gene

Forward (5’ → 3’)

Reverse (5’ → 3’)

Function

B2M

AAGTATACTCACGCCACCCA

CAGGCGTATGTATCAGTCTC

Endogenous
housekeeping
gene

SIRT1

CAGTGAGAAAATGCTGGCCTA

TTGGTGGTACAAACAGGTATTGA

Energy sensor
that is activated
by high
NAD+/NADH
ratio; associates
with PPARα to
stimulate fatty
acid oxidation

AMPKα

CTGTACCAGGTCATCAGTACACC

AGTACACACGTAGTTCGTCCTGC

Energy sensor
that is activated
by high
AMP/ATP ratio;
drives catabolic
processes

AKT2

GAGGACCTTCCATGTAGACT

CTCAGATGTGGAAGAGTCAC

Serine/threonine
kinase that
regulates
glucose uptake
by insulin

GLUT2

GGTCAGAACTACCTCTCTTTG

GTGTGTGTGGAATTGTCCTC

Plasma
membrane
glucose sensor
that promotes
glucose secretion
during
gluconeogenesis
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Gene

Forward (5’ → 3’)

Reverse (5’ → 3’)

Function

SREBP1c

AAGACATGCTCCAGCTCATC

TACGCACGTCGAACGAAACT

Transcription
factor activated
by insulin;
induces de novo
lipogenesis

PPAR-γ

GTCAGTGTCGGTTTCAG

CAGATCAGCAGACTCTGGGT

Nuclear receptor
that promotes
lipid uptake

ACC

GTCCCCAGGGATGAACCAATA

GCCATGCTCAACCAAAGTAGC

Enzyme that
converts acetylCoA to malonyl
CoA, generates
fatty acids (FA);
malonyl CoA
inhibits beta
oxidation by
preventing FA
from associating
with carnitine
which hampers
them from
travelling to the
mitochondria

SCD1

GAGGCCTGTACGGGATCATA

TGAGAGAAGAAGAAGCCACGG

Enzyme
activated by
SREBP1c,
converts
saturated FA to
monounsaturated
FA
which can be
synthesized into
triglycerides
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Gene

Forward (5’ → 3’)

Reverse (5’ → 3’)

Function

CPT1

CTCAGTGGGAGCGACTCTTCA

GGCCTCTGTGGTACACGACAA

Enzyme that
creates carnitine so
fatty acids can
enter mitochondria
to produce ATP;
inhibited by
malonyl CoA

MTTP

CTCTTGGCAGTGCTTTTTCTCT

GAGCTTGTATAGCCGCTCATT

Transfers
triglycerides onto
APOB100 in the
endoplasmic
reticulum

APOB

CGTGGGCTCCAGCATTCTA

TCACCAGTCATTTCTGCCTTTG

Apolipoprotein
responsible for
binding lipids and
shuttling VLDL to
the Golgi

SAR1a

GGGCCGTTGTAAGCATCAATA

TTCCAGATTTCTTGTAGAGTCCTAGGA

COPII coat protein
that enables VLDL
transport to the
Golgi apparatus

SAR1b

GCTAAAAAGGCAGGGCTATGG

GGCCGCTGCTAATCGATGTA

COPII coat protein
that enables VLDL
transport to the
Golgi apparatus

SVIP

TGTGCTTCCCGTGTCCCG

TGCCTCCACCGACTGGATAT

Component of
VTV that enables
ER to Golgi
delivery of VLDL

Sec22b

CATTGATAGCCGTGCTCGGAG

CGCATCTTCAAGTACTTCGCATC

Component of
VTV that enables
ER to Golgi
delivery of VLDL
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Gene

Forward (5’ → 3’)

Reverse (5’ → 3’)

Function

APOA1

CCACACCCTTCAGGATGAAAG

TGGCTCCCTGTCAGGAAGAC

Major component
of HDL; moves
HDL to liver for
reverse cholesterol
transport

APOA4

CAGCTGACCCCATACATCCAG

TCATCGAGGTGTGCAGGTTG

Component of
HDL that mediates
reverse cholesterol
transport

LXR

TGCCATCAGCATCTTCTCTG

GGCTCACCAGCTTCATTAGC

Nuclear receptor
that functions as a
cholesterol sensor
and activates ATPbinding cassette
transporters

ABCG5

ATCCAACACCTCTATGCTAAATCAC

TACATTATTGGACCAGTTCAGTCAC

Activated by LXR
and stimulates
cholesterol efflux;
transports
cholesterol into the
bile

CYP7A1

CCAGGGAGATGCTCTGTGTTC

ACCCAGACAGCGCTCTTTGAT

Enzyme that
modulates
cholesterol
catabolism by
generating bile
acids

MCP1

CACACTCAGATCCAATGGGGA

AGTAGAAAGGGCCTGAACAGC

Pro-inflammatory
cytokine that
gathers monocytes
and macrophages
to sites of
inflammation
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Gene
CD68

Forward (5’ → 3’)

Reverse (5’ → 3’)

Function

GACACTTCGGGCCATGTT

GAGGAGGACCAGGCCAAT

Expressed by
monocytes and
macrophages

NFKB1

GACCACTGCTCAGGTCCACT

TGTCACTATCCCGGAGTTCA

Transcription
factor that
activates M1 proinflammatory
macrophages

TNFa

CCACGCTCTTCTGTCTACTG

GCTACAGGCTTGTCACTCG

Inflammatory
cytokine produced
by monocytes and
macrophages
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Table 2:Human Primers

Gene

Forward

Reverse

B2M

5’ – GAGTATGCCTGCCGT – 3’

5’ – CGGCATCTTCAAACCTCCAT – 3’

SIRT1

5’ – CTTCAGGTCAAGGGATGGTAT – 3’

5’ – GCGTGTCTATGTTCTGGGTAT – 3’

AMPKa

5’ – TGCGTGTACGAAGGAAGAATCC – 3’

5’ – TGTGACTTCCAGGTCTTGGAGTT – 3’

PPAR-γ

5’ – GACCACTCCCACTCCTTT – 3’

5’ – CGACATTCAATTGCCATGAG – 3’

SCD1

5’ – GCAGGACGATATCTCTAGCT – 3’

5’ – GTCTCCAACTTATCTCCTCCATTC – 3’

ACC

5’ GTCCCCAGGGATGAACCAATA – 3’

5’ – GCCATGCTCAACCAAAGTAGC – 3’

PPARα

5’ – TGAACGATCAAGTGACATTGC – 3’

5’ – TGGGAAGAGAAAGATATCG – 3’

PGC1a

5’ – TCAGTCCTCACTGGTGGACA – 3’

5’ – TGCTTCGTCGTCAAAAACAG – 3’

CPT1

5’ – TGAGGTGCTCTCGGAACCCT – 3’

5’ – CTCGCCTGCAATCATGTAGG – 3’

MTTP

5’ – TGATATTTCAGGTGCAATGGAG – 3’

5’ – CGGGTTTTAGACTCACGATACC – 3’

APOB100

5’ – GGAGCTGCTGGACATTGCTA – 3’

5’ – ATGGCAGCTTTCTGGATCAT – 3’

Sar1a

5’ – TTGGGCTTTATGGACAGACC – 3’

5’ – CTTGCCTCTTGAGCACACTG – 3’

Syntaxin5a

5’ – GGCTCCATCTTTCAGCAGTTGG – 3’

5’ – GTTGGAGGTGACAGACTGGAAG – 3’

Sec22b

5’ – GCCAGGATGCGAAGTACTTGA – 3’

5’ – TACAGCTACTGCTGCAAGTTTGG – 3’

APOA1

5’ – CCCTGGGATCGAGTGAAGGA – 3’

5’ – CTGGGACACATAGTCTCTGCC – 3’

APOE

5’ – TGTCTGAGCAGGTGCAGGAG – 3’

5’ – TCCAGTTCCGATTTGTAGG -3’

LXR

5’ – AAGCCCTGCATGCCTACGT – 3’

5’ – TGCAGACGCAGTGCAAACA – 3’

ABCG5

5’ – CCCAAGGGACTCCGGGGTCA – 3’

5’ – GACCCATGGACCCTCCGGGG – 3’
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RESULTS
4.1: miRNA Profiling of Liver in vivo and candidate miR-34a
miRNA have promising properties to be therapeutic owing to their small size and
capacity to broadly regulate physiology dependent on the sequence of mRNA they
complement. To identify a cohort of miRNAs influenced by CR, we completed an
extensive literature and bioinformatic search to determine candidate miRNAs involved in
the pathology of fatty liver. [18] Of the miRNAs that were studied, we found both miR-34a
and miR-149 to be most significantly associated with genotype and diet (Fig 2A and 2B).
The significance of the interaction term for miR-149 (P<0.001, Fig 2B) suggests this
miRNA has overlapping roles to regulate Ames dwarf and calorie restricted liver, while
other miRNAs 34a (Fig 2A), 21 (Fig 2D), and 378c (Fig 2I) have weak significance
(P<0.05) for the interaction term, which may suggest less overlap in the mechanism of
CR and genotype on liver metabolism and homeostasis. miR-34a appears to be regulated
by both genotype and diet; namely, while CR significantly downregulated the expression
of miR-34a in the liver, Ames dwarf mice had a significant reduction in this microRNA
regardless of diet. Studying the difference in mechanism by which diet and Ames dwarf
genotype influence lifespan may provide insights for increasing longevity.
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Figure 2: Expression of metabolism miRNAs in liver controlled by genotype (wild type or
Ames dwarf) and treatment (ad libitum (AL) or caloric restriction (CR)), with y-axis equal
to miRNA expression relative to control miR-16, with 8-11 biological replicates. Two-way
analysis of variance (ANOVA) was performed with Tukey’s post-hoc multiple comparison
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test. (* or *1) P<0.05, (** or *2) P<0.01, (*** or *3) P<0.001, (**** or *4) P<0.0001 using the
SigmaPlot v14.0 software.
4.2: Calorie restriction and Ames dwarf genotype decrease oxidative stress and de novo
lipogenesis in the Liver
SIRT1 was studied due to its role as a major regulator and sensor of energy
metabolism in the liver. [23] SIRT1 is also a direct target of miR-34a and has been shown
to have protective effects when overexpressed in the liver. [24] Lipid, glucose, and
oxidative metabolic processes are regulated by SIRT1 to retain homeostasis and prevent
pathogenesis of NAFLD. [25] CR and Ames dwarf genotype have been shown to have
significant effects on liver energy metabolism such as inducing changes in the
NAD+/NADH ratio in the df/df-CR model or suppressing oxidative stress in the df/df-AL
liver. [25] We hypothesized that lipid trafficking and metabolism would be altered in
response to CR and df/df genotype, so we investigated an array of lipid uptake and de
novo lipogenesis genes; CD36, SREBP1, PPARγ, ACC, SCD1, alongside SIRT1 (Fig 3).
CD36 is a plasma membrane protein that facilitates the uptake and accumulation
of fats in the liver [14, 19]We found upregulation of CD36 translocase in df/df mice
regardless of diet indicating the requirement of fatty acid fuel use in their livers, perhaps
due to their small body size and serious need for energy (Fig 3B). In the normal mice, CR
does not influence CD36 levels and indicates genotypic rather than dietary effects
regulate this gene and components of lipid metabolism. PPAR-γ is a nuclear receptor that
initiates the transcription of SREBP1, a protein which is involved with lipogenesis.[14, 19]
In the Ames dwarf mice under CR, PPAR-γ is upregulated with interactive effect observed
(Fig 3C). In contrast, downregulation was seen in the N-CR mice suggesting alternative
mechanisms by which diet and genotype influence lipid metabolism and further indicating
that CR impairs the accumulation of hepatic lipids.
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Although CD36 and PPAR-γ levels are influenced by genotypic effects, CR
appears to suppress SREBP1 expression providing an example of dietary, and not
genotypic, mediated improvement to liver lipid trafficking homeostasis (Fig 3D). ACC is
involved in the process of triglyceride retention by preventing the conversion of acetyl
CoA to malonyl CoA. [21] While CR decreases the expression of ACC, Ames dwarf
genotype appears to attenuate the effects of CR on ACC (Fig 3E). Ames dwarf-AL ACC
expression is decreased relative to N-AL, providing an example where the effect of these
two treatments on liver metabolism overlap and do not combine additively. Lastly, the
conversion of saturated fatty acids to monosaturated fatty acids is regulated by SCD1
and is not significantly affected by Ames dwarf genotype or CR Overall, this data provides
examples of non-additive, additive, and interactive effects of these treatments in different
processes of lipid metabolism in the liver between diet and genotype.[22]
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Figure 3: Expression of lipid metabolism mRNAs in liver controlled by genotype
(wild type or Ames dwarf) and treatment (ad libitum (AL) or caloric restriction (CR)),
with y-axis equal to mRNA expression relative to control beta-2-microglobulin
(B2M), with 8-11 biological replicates. Two-way analysis of variance (ANOVA) was
performed with Tukey’s post-hoc multiple comparison test. (* or *1) P<0.05, (** or
*2) P<0.01, (*** or *3) P<0.001, (**** or *4) P<0.0001 using the SigmaPlot v14.0
software.
4.3: Fatty Acid Oxidation and Insulin Signaling is influenced by CR and Ames dwarf
genotype
PGC1 influences both fatty acid oxidation and the insulin signaling pathway by
regulating the ratio of insulin receptor substrates 1 and 2 (IRS1 and IRS2) in the
hepatocytes. Increased IRS2 expression inhibits gluconeogenesis and prompts the
activation of AKT. During CR, glucagon induces gluconeogenesis to secrete glucose for
energy in the peripheral tissues, while dwarf genotype has been shown to increase
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deacetylation of PGC1. [16] Therefore, to understand the relationship between fatty acid
oxidation and insulin signaling in the liver, we studied CR and df/df genotype in attempt
to elucidate how they enhance longevity. We found that PGC1α regulates
gluconeogenesis and the hepatic response to CR by stimulating lipid catabolism,
preventing fatty liver and insulin resistance.
Alongside, we looked at the mRNA expression of GLUT2 and AKT2, proteins
central to glucose uptake and metabolism. [16] We studied GLUT2 because it is important
for the transport of glucose. We studied AKT2 due to its response to insulin and
involvement in senescence. Interestingly, GLUT2 appears to significantly correlate with
the combination of diet and genotype. The synergistic effects of df/df genotype and diet
appear to increase the expression of GLUT2 suggesting that these treatments may
increase insulin sensitivity and enable a response to gluconeogenesis.
Lastly, we observed the effects of CR and df/df genotype on genes that regulate
fatty acid oxidation. Specifically, the upregulation of PGC1a is believed to activate PPARa
and initiate the transcription of CPT1, a gene that generates carnitine in order to transport
fatty acids to the mitochondria to undergo beta oxidation. Dysregulation of these process
is involved with hepatic steatosis. [14, 18, 24] Our results show an increase in PGC1α in
the df/df genotype and diet in an additive and not interactive manner. We found an
epistatic effect of diet and genotype which suggests PPARα is involved in an overlapping
mechanism between the two treatments, although this was P<0.05. We found an
upregulation of CPT1 in response to CR and dwarf genotype, while another epistatic
interaction was found with diet and genotype suggesting both treatments have
overlapping adaptions in the organism’s aerobic energy sources.
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Figure 4: Expression of insulin-associated (A, B) and fatty acid oxidation
associated (C-D) mRNAs in liver controlled by genotype (wild type or Ames dwarf)
and treatment (ad libitum (AL) or caloric restriction (CR)), with y-axis equal to
mRNA expression relative to control beta-2-microglobulin (B2M), with 8-11
biological replicates. Two-way analysis of variance (ANOVA) was performed with
Tukey’s post-hoc multiple comparison test. (* or *1) P<0.05, (** or *2) P<0.01, (***
or *3) P<0.001, (**** or *4) P<0.0001 using the SigmaPlot v14.0 software.
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4.4: CR Improves VLDL Transport in the Ames dwarf Liver
While df/df genotype upregulates the expression of APOB100, df/df-CR mice
appear to significantly generate VLDL. Despite this increase in VLDL, CR appears to
improve the expression of CIDEB and COPII proteins Sar1a and Sar1b in the df/df
genotype and allows the efficient transport of VTV to the Golgi apparatus. This is further
supported by the upregulation of fusion proteins Sec22b and Syntaxin5a in the df/df-CR
mice.[17]

4.5: CR Improves Reverse Cholesterol Transport in the Ames dwarf Liver
Although dwarf genotype appears to inhibit the expression of APOA1 and APOA4,
APOE expression is significantly upregulated due to CR. This indicates that there is an
increase in HDL due to diet which may subsequently trigger reverse cholesterol transport.
CR appears to stimulate LXR, thereby prompting the activation of ABCG5 and CYP7A1.
In turn, there is improved cholesterol efflux and oxidation, reducing cholesterol deposition
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in the liver. Overall, CR appears to regulate this process, with less genotypic effects
noted.[14, 19]

Expression of fatty acid oxidation associated miRNAs in liver controlled by
genotype (wild type or Ames dwarf) and treatment (ad libitum (AL) or caloric
restriction (CR)), with y-axis equal to miRNA expression relative to control beta-2microglobulin (B2M), with 8-11 biological replicates. Two-way analysis of variance
(ANOVA) was performed with Tukey’s post-hoc multiple comparison test. (* or *1)
P<0.05, (** or *2) P<0.01, (*** or *3) P<0.001, (**** or *4) P<0.0001 using the
SigmaPlot v14.0 software.

4.6: Ames dwarf Mice Undergo Autophagic Processes
Since inflammation is a marker for liver injury, we investigated the activity of the
transcription factor NFKB and its influence on TNFa, a pro-inflammatory gene. Alongside,
we quantified monocyte and macrophage activity by measuring the activity of MCP1 and
further explored the inflammation induced by these cells by checking the expression of
CD68. [18]The additive effects of diet and genotype appear to upregulate the expression
of MCP1 in the Ames dwarf liver. Meanwhile, the expression of CD68 is significantly
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increased by diet alone. Alongside, NFKB and TNFa are upregulated due to df/df
genotype.

Figure 5: qPCR Expression of inflammation associated mRNAs in liver controlled
by genotype (wild type or Ames dwarf) and treatment (ad libitum (AL) or caloric
restriction (CR)), with y-axis equal to mRNA expression relative to control beta-2microglobulin (B2M), with 8-11 biological replicates. Two-way analysis of variance
(ANOVA) was performed with Tukey’s post-hoc multiple comparison test. (* or *1)
P<0.05, (** or *2) P<0.01, (*** or *3) P<0.001, (**** or *4) P<0.0001 using the
SigmaPlot v14.0 software.
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Figure 6: PCA biplot - Group 1-normal mice under AL treatment; group 2-dwarf
under AL treatment; group 3-normal under CR treatment; and group 4-dwarf under
CR treatment.

Table 3: Gene significance by Diet and Genotype (cutoff P<0.05)
-

indicates downregulation; + indicates upregulation; NS represents no significance

Gene
miR-34a
SIRT1
CD36
SREBP1
PPAR-γ
ACC
SCD1
PGC1α
PPARα
CPT1
GLUT2
AKT2
APOB100
Sar1a
Sar1b

Diet
+
NS
NS
NS
+
NS
+
+
+
NS
+
+

Genotype
+
+
+
NS
+
+
NS
+
+
+
NS
NS
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Interaction
NS
NS
NS
+
NS
NS
NS
+
+
NS
NS
NS
NS
NS

Sec22b
Gene
Syntaxin5a
Cideb
APOA1
APOA4
APOE
LXR
ABCG5
CYP7A1

NS
Diet
+
+
NS
NS
+
+
+
+

NS
Genotype
NS
NS
NS
NS
NS
NS

+
Interaction
NS
NS
NS
NS
NS
NS
NS
NS

Gene
mir34a
SIRT1
CD36
SREBP1
PPAR-γ
ACC
SCD1
PGC1a
PPARa
CPT1
GLUT2
AKT2
APOB100
Sar1a
Sar1b
Sec22b
Syntaxin5a
CIDEB
APOA1
APOA4
APOE
LXR
ABCG5

df/df-AL
+
+
No change
+
No change
+
No change
+
+
+
+
+
No change
No change
No change
No change
No change
+
No change

N-CR
+
No change
+
+
+
+
+
+
No change
No change
No change
+
No change
+
+
+
+

df/df-CR
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
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CYP7A1

+

+

+

Figure 7: HepG2 cells were seeded at a density of 2.0*10^5 cells. Following 48
hours, the cells were transfected (Panel 6A) using Hiperfect transfection reagent,
with 5nM of miR-34a for the mimic samples. Cells were collected 48 hours
following transfection (Panel 6B and 6C) for RNA isolation and subsequent qPCR.

4.7: Transfection of miR-34a in HepG2 Cells to Confirm its Influence on Lipid
Homeostasis
After selecting miR-34a as a candidate biomarker, we investigated if this molecule
is directly involved in the regulation of SIRT1, AMPK, PPARα and downstream lipid
metabolic genes.
qPCR indicates that there was significant upregulation of miR-34a after 48hours
of transfection. Although insignificant, there was less expression of SIRT1 and AMPK
which may be attributed to replenishment of cell media every two days. This may suggest
that CR or fasting are more potent regulators of these genes under declining energy
levels. However, it also indicates that miR-34a may potentially impair energy sensing by
downregulating the expression of these genes during nutrient deprived states.
Surprisingly, reduced de novo lipogenesis was indicated by decreased PPAR-γ
and SCD1 levels along with similar levels of ACC between control and mimic cells. It
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appears that miR-34a may inhibit the retention of fats in the liver but may have
downstream effects and thus influence the development of fatty liver. Specifically, less
fatty acid oxidation was observed due to significantly decreased levels of PPARa, PGC1a,
and CPT1 supporting the idea that this miRNA may prompt NALFD.
Although decrease in APOB100 and MTTP was unexpected due to hypothesized
increase in generation of VLDL, there was a decrease in COPII transport proteins and
fusion proteins indicating impaired ER to golgi trafficking. Alternatively, since there was
decreased de novo lipogenesis in the cells following transfection with miR-34a there may
also be less need for VLDL generation and transport.
Lastly, decrease in HDL lipoproteins and LXR expression resulted in decreased
expression of ABCG5 which is involved with bile synthesis and cholesterol efflux. In all,
these results indicate that miR-34a may not influence de novo lipogenesis or VLDL
transport but may rather be involved with fatty acid oxidation and cholesterol balance
which may result in the pathogenesis of fatty liver.
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Figure 7: miR-34a transfection efficiency was verified via qPCR (7A). Thereafter,
the expression of energy-sensing (7B and 7C), lipogenesis associated (7D-7F),
fatty acid oxidation (7G-7I), lipid trafficking (7J-7N), and reverse cholesterol
transport (7O-7R) mRNAs was assessed. B2M served as internal control, with n=
16 biological replicates for both control and mimic groups. One-way analysis of
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variance (ANOVA) was performed with Welch’s correction. (*) P<0.05, (**) P<0.01,
(***) P<0.001, (****) P<0.0001 using the SigmaPlot v14.0 software.
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DISCUSSION & CONCLUSIONS
NAFLD is a multifaceted condition that is influenced by the consequences of
nutritional overload which include de novo lipogenesis, impaired VLDL transport, and
dyslipidemia. The absence of drug therapies to help combat NAFLD is a major
disadvantage as adherence to lifestyle modifications such as diet and exercise is ill-fated
with only 50% compliance rate[3]. Therefore, understanding the epigenetic regulation of
CR on miRNAs and downstream metabolic processes is a pivotal turning point which may
lead to the discovery of novel remedies that could curtail the pathogenesis of this
idiopathic disease. In the present study, we investigated the effects of CR on metabolic
signaling pathways in the livers of long-living df/df mice and thereby aimed to elucidate
the mechanisms by which both diet and genotype impact longevity and the progression
of this age-associated illness.
miRNAs are powerful endogenous biomarkers that work by silencing posttranscriptional gene expression. They play an important role in regulating several
physiological processes including cell metabolism. miRNA profiling in the livers of AL and
CR animals revealed significant downregulation of miR-34a in df/df-AL, N-CR, and df/dfCR mice suggesting the overlapping yet different mechanisms by which diet and
genotype influence lipid trafficking, evidenced by significant interaction terms for some
genes, gene alignment along both axis (Supl Fig 3), and the shift of the centroid/ellipsesize between treatment groups (Supl Fig 4). Literature and bioinformatic search
suggested that this miRNA has been implicated in fatty liver by allegedly downregulating
the expression of SIRT1 and AMPK ultimately resulting in increased de novo lipogenesis
and impaired VLDL transport, fatty acid oxidation, and reverse cholesterol transport. [14]
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We hypothesized that CR and df/df livers would correspondingly have increased
expression of SIRT1 and AMPK. We speculated that CR diet and df/df genotype
increased insulin sensitivity, improved VLDL and reverse cholesterol transport while
increasing fatty acid oxidation to improve liver function.
CR downregulated the expression of miR-34a and was interestingly inhibited in the
df/df genotype regardless of diet suggesting that there are different mechanisms by which
CR and genotype influence the expression of this miRNA. Nutrient deficiency due to CR
increased the cellular NAD+/NADH ratio and prompted increased expression of SIRT1 to
signal the need for energy. In the df/df model, upregulation of SIRT1 in AL diet relative to
normal mice may be attributed to small body size and suggests that minimized oxidative
stress may contribute to the prolonged longevity of these mice. Coupled with CR, df/df
mice exhibited higher levels of SIRT1 than both df/df-AL and N-CR animals suggesting
nonoverlapping functions of diet and genotype on energy sensing of the cell.
To examine the effects of diet and genotype on de novo lipogenesis, we observed
fatty acid uptake by quantifying the expression of the CD36 plasma membrane
translocase and PPARγ. Our findings suggest that these genes are upregulated by df/df
genotype, and we maintain that this may be due to high cellular demands resulting from
their small body size. In the N-CR mice, downregulation of PPARγ suggests decreased
lipogenesis and demonstrates that CR curbs fatty liver. Alongside, this shows that diet
and genotype have different mechanisms by which they regulate lipid homeostasis.
Further, CR decreased the expression of SREBP1 which suggests inhibition of de novo
lipogenesis and supports the idea that low cellular energy encourages lipid trafficking.
Suppression of ACC due to both diet and genotype demonstrates that df/df AL mice have
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a healthy balance of lipid import and export despite increased expression of CD36 and
PPARγ. The PPAR proteins γ and α represent a unique class in this study in that both of
their interaction terms were significant, suggesting a synergy between diet and genotype
that affects these proteins.
To confirm the oxidation of these fatty acids, we explored the expression of insulin
signaling genes GLUT2, AKT2, and PGC1α. The small size of the df/df mice may cause
them to rely on glucose for energy and this process is augmented under long-term CR as
seen by elevated levels of GLUT2 in df/df-CR mice. Gluconeogenesis prompted activation
of AKT2 in the df/df liver and this was enhanced by interactive effects of dwarf genotype
and CR diet. Alongside, gluconeogenesis is regulated by PGC1α and the expression of
this gene was upregulated regardless of diet but heightened under CR. Lastly, both
PPARα and CPT1 expression were increased in the df/df-CR livers. As such, the small
size of the dwarf mice may prompt lipid catabolism under CR due to the activation of
gluconeogenesis.
Next, we aimed to understand VLDL transport in response to diet and genotype.
We observed that df/df mice had increased levels of APOB100 but exhibited improved
VLDL transport due to CR. Under CR, these mice displayed increased expression of lipid
trafficking genes. Alongside, while the expression of APOA1 and APOA4 was
downregulated in df/df mice, CR upregulated the expression of APOE and consequently
improved cholesterol efflux and bile acid biosynthesis thereby improving reverse
cholesterol transport. Blood plasma from these mice could provide more useful
information of HDL to LDL balance. High HDL could indicate increasing RCT in liver, and
low LDL could indicate either impaired VLDL transport or decreased retention of fats in
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the liver. HDL to LDL ratio would give better overall perspective on the overall cholesterol
homeostasis of these mice. Lastly, CR may induce inflammatory processes in the df/df
liver due to the increased presence of monocytes and macrophages which reveals that
these mice may be undergoing autophagic mechanisms due to their small body size and
that this process may improve lipid homeostasis.
To verify the influence of miR-34a on these processes, we transfected the HepG2
cancer cell line with 5nM of mimic for miR-34a. We hypothesized that upregulation of
miR-34a in HepG2 cells would correspondingly decrease the expression of SIRT1 and
AMPK. Alongside, we maintained that the expression of this endogenous molecule would
prompt hepatic steatosis and increased cholesterol deposition. Namely, we speculated
that miR-34a would increase de novo lipogenesis (CD36, SREBP1, PPARγ, ACC, SCD1),
inhibit VLDL transport (APOB100, MTTP, Sar1a, Sar1b, Sec22b, Syntaxin5a), decrease
fatty acid oxidation (CPT1a, PPARa, PGC1a), and impair reverse cholesterol transport
(APOA1, APOA4, APOE). Furthermore, we surmised that miR-34a expression in the AL
model would decrease cholesterol efflux (LXR, ABCG5) and bile acid biosynthesis
(CYP7A1). Studying the associated genes with longevity and lipid trafficking in vitro using
mimic for miR-34a enabled us to validate our findings. Our findings indicate that miR-34a
impairs fatty acid oxidation and reverse cholesterol transport. Sirt1 and AMPK in cells
may not be affected because of NAD+/NADH and AMP/ATP ratios being low since the
cells are constantly being given media with nutrients and growth supplement. Perhaps,
the cells must be starved indicating that miR-34a is involved in lipid trafficking by
association with SIRT1 under calorie restriction or nutrient deficiency. Of note, Western
blot of energy sensing biomarkers SIRT1 and AMPK was not checked in vitro and may
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show significant decrease in protein expression. Lastly, the upregulation of this miRNA
did not induce de novo lipogenesis or hinder VLDL transport.
This information reveals that CR improves metabolic processes in the Ames dwarf
liver via downregulation of miR-34a and subsequent improvement of fatty acid oxidation
and cholesterol efflux. Although de novo lipogenesis and VLDL transport is also mediated,
these processes do not appear to be influenced by the regulation of miR-34a. This
information also elucidates the importance of understanding natural therapies in order to
find biomarkers that can prevent the progression of age-related disease such as NAFLD.
We expect that the findings in the present study will provide pivotal information that will
improve the quality of life of our species.

Figure 8: CR Mediates Lipid Metabolism in the Ames dwarf Liver. 30% CR upregulates
the expression of SIRT1 thereby prompting suppression of miR-34a. In turn, this results
in inhibition of fatty liver by upregulating fatty acid oxidation and reverse cholesterol
transport. (Created with BioRender.com.)
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APPENDIX A: HEATMAP
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Supplementary Figure 1: Heatmap showing the relative gene expression of each
gene in different samples. Outiers are labeled grey.
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APPENDIX B: SPEARMAN CORRELATION
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Supplementary Figure 2: Heatmap showing the pairwise correlation among the 34
genes in each group of samples. (A) and (B) for AL treatment on normal and dwarf
animal respectively; (C) and (D) for CR treatment on normal and dwarf animal
respectively. The colored squares indicate the correlations are significant with pvalue<0.05.
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APPENDIX C: PRINCIPAL COMPONENT ANALYSIS BIPLOT
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Supplementary Figure 3: PCA-biplot showing the contribution of each gene on the
two major principal components.
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